Oral cannabinoid product with lipid component

Patent metadata

Field	Value
Publication number	US-11839602-B2
Application number	US-202017104926-A
Country	US
Kind code	B2
Filing date	Nov 25, 2020
Priority date	Nov 25, 2020
Publication date	Dec 12, 2023
Grant date	Dec 12, 2023

Abstract

Meltable compositions configured for oral use, the compositions including at least one cannabinoid or cannabimimetic, are provided. The compositions include one or more fillers, typically a sugar alcohol, and a lipid. A method of forming such compositions is also provided.

First claim

What is claimed is:

1. A composition in meltable form, configured for oral use, the composition comprising:
a cannabinoid or cannabimimetic;
a filler comprising at least one sugar alcohol in an amount of from about 38 to about 58% by weight, based on the total weight of the composition; and
a lipid in an amount of from about 35 to about 58% by weight, based on the total weight of the composition;
wherein all or a portion of the lipid has a melting point from about 36° C. to about 45° C., wherein the meltable form comprises the composition as a homogenous mixture, wherein the composition is substantially free of tobacco, and wherein the composition has a moisture content from about 0.1 to about 1% by weight.

2. The composition of claim 1 , wherein the cannabinoid is selected from the group consisting of tetrahydrocannabinol (THC), cannabidiol (CBD), and combinations thereof.

3. The composition of claim 1 , wherein the cannabinoid is selected from the group consisting of cannabigerol (CBG), cannabichromene (CBC), cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol (CBN), cannabinodiol (CBDL), cannabicyclol (CBL), cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), cannabigerol monomethyl ether (CBGM), cannabinerolic acid, cannabidiolic acid (CBDA), cannabinol propyl variant (CBNV), cannabitriol (CBO), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarinic acid (THCV A), and combinations thereof.

4. The composition of claim 1 , wherein the cannabinoid or cannabimimetic is present in an amount of from about 0.1 to about 20% by weight, based on the total weight of the composition.

5. The composition of claim 1 , wherein the composition further comprises an additional active ingredient selected from the group consisting of botanical ingredients, stimulants, amino acids, nicotine components, pharmaceutical ingredients, nutraceutical ingredients, medicinal ingredients, terpenes, and combinations thereof.

6. The composition of claim 5 , wherein the composition comprises a terpene selected from the group consisting of beta-caryophyllene, linalool, limonene, beta-citronellol, linalyl acetate, pinene (alpha or beta), geraniol, carvone, eucalyptol, menthone, iso-menthone, piperitone, myrcene, beta-bourbonene, germacrene, and combinations thereof.

7. The composition of claim 1 , wherein the lipid is an oil selected from the group consisting of palm oil, partially hydrogenated palm oil, hydrogenated palm oil, palm kernel oil, partially hydrogenated palm kernel oil, hydrogenated palm kernel oil, soybean oil, partially hydrogenated soybean oil, hydrogenated soybean oil, sunflower oil, partially hydrogenated sunflower oil, hydrogenated sunflower oil, cottonseed oil partially hydrogenated cottonseed oil, hydrogenated cottonseed oil, coconut oil, partially hydrogenated coconut oil, hydrogenated coconut oil, and combinations thereof.

8. The composition of claim 1 , wherein the sugar alcohol is selected from the group consisting of isomalt, erythritol, sorbitol, arabitol, ribitol, maltitol, dulcitol, iditol, mannitol, xylitol, lactitol, and combinations thereof.

9. The composition of claim 1 , wherein the sugar alcohol is isomalt.

10. The composition of claim 1 , further comprising lecithin.

11. The composition of claim 10 , wherein the lecithin is present in an amount of from about 0.5 to about 1.5% by weight, based on the total weight of the composition.

12. The composition of claim 1 , wherein the lipid is selected from the group consisting of palm oil, palm kernel oil, sunflower oil, and combinations thereof.

13. The composition of claim 12 , wherein the lipid is:
palm oil, palm kernel oil, or a mixture thereof, present in a total amount from about 35 to about 53% by weight; and
sunflower oil, present in an amount of from about 2 to about 6% by weight, based on the total weight of the composition.

14. The composition of claim 1 , further comprising at least one additional component selected from additional active ingredients, sweeteners, salts, flavorants, buffers, emulsifiers, colorants, processing aids, and combinations thereof.

15. The composition of claim 1 , wherein the composition is substantially free of nicotine.

16. The composition of claim 1 , comprising the cannabinoid or cannabimimetic in an amount of from about 0.1 to about 5% by weight, based on the total weight of the composition, and further comprising;
a salt in an amount of from about 0.5 to about 1.5% by weight, based on the total weight of the composition;
a sweetener in an amount of from about 0.05 to about 0.5% by weight, based on the total weight of the composition; and
a flavorant in an amount of from about 0.5 to about 1.5% by weight, based on the total weight of the composition.

Assignees

• Nicoventures Trading Ltd

Inventors

• Gerardi Anthony Richard
• Poole Thomas H
• Zawadzki Michael Andrew
• Spielbauer Kristen Ann
• Alderman Steven Lee
• Nestor Timothy Brian

Classifications

• A61K31/192

  having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid  {(cannabinoids A61K31/658)} · CPC title

• A61K31/658 Primary

  o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol · CPC title

• A61K31/352 Primary

  condensed with carbocyclic rings, e.g. methantheline  {(cannabinoids A61K31/658)} · CPC title

• A61K9/1694

  resulting in granules or microspheres of the matrix type containing more than 5% of excipient · CPC title

• A61K31/05

  Phenols {(cannabinoids A61K31/658)} · CPC title